CHAMPIONS ONCOLOGY INC's ticker is CSBR and the CUSIP is 15870P307. A total of 31 filers reported holding CHAMPIONS ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68 | -1.4% | 11 | 0.0% | 0.00% | – |
Q2 2023 | $69 | – | 11 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 11 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 11 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 11 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 11 | -99.7% | 0.00% | – |
Q2 2021 | $45,000 | -80.3% | 4,379 | -78.4% | 0.00% | – |
Q1 2021 | $229,000 | +12.8% | 20,287 | +7.8% | 0.00% | – |
Q4 2020 | $203,000 | +97.1% | 18,827 | +69.0% | 0.00% | – |
Q3 2020 | $103,000 | -17.6% | 11,140 | -14.8% | 0.00% | – |
Q2 2020 | $125,000 | +635.3% | 13,073 | +480.2% | 0.00% | – |
Q1 2020 | $17,000 | -99.2% | 2,253 | -98.2% | 0.00% | – |
Q3 2018 | $2,162,000 | +21520.0% | 123,770 | +4850.8% | 0.00% | – |
Q3 2017 | $10,000 | +66.7% | 2,500 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | – |
Q1 2017 | $8,000 | +300.0% | 2,500 | +270.4% | 0.00% | – |
Q4 2015 | $2,000 | – | 675 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Battery Partners IX, LLC | 1,953,549 | $7,111,000 | 7.42% |
NEA Management Company, LLC | 1,562,500 | $5,688,000 | 0.25% |
SHEPHERD KAPLAN KROCHUK, LLC | 21,564 | $78,000 | 0.05% |
Perceptive Advisors | 366,973 | $1,335,000 | 0.04% |
Granite Investment Partners, LLC | 139,698 | $509,000 | 0.03% |
Sandy Spring Bank | 8,333 | $30,000 | 0.00% |
Veritas Investment Management (UK) Ltd | 2,083 | $8,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,753 | $6,000 | 0.00% |
VANGUARD GROUP INC | 152,722 | $553,000 | 0.00% |
MORGAN STANLEY | 3,500 | $13,000 | 0.00% |